表紙
市場調查報告書

微創 (MIS) 脊椎移植的台灣市場:2018年∼2024年

Minimally Invasive Spinal Implant Market Report Suite | Taiwan | 2018-2024 | MedSuite (Includes 5 Reports)

出版商 iData Research Inc. 商品編碼 795316
出版日期 內容資訊 英文 509 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
微創 (MIS) 脊椎移植的台灣市場:2018年∼2024年 Minimally Invasive Spinal Implant Market Report Suite | Taiwan | 2018-2024 | MedSuite (Includes 5 Reports)
出版日期: 2018年08月02日內容資訊: 英文 509 Pages
簡介

本報告提供台灣的微創 (MIS) 脊椎移植市場相關調查分析,提供市場分析 (銷售數量,ASP,市場金額·成長率趨勢),再加上推動市場要素與阻礙要素,競爭分析等相關的系統性資訊。

摘要整理

台灣的微創 (MIS) 脊椎移植市場概要

競爭分析

市場趨勢

市場發展

治療數量

對象市場

主要的調查更新

版本履歷

第1章 調查手法

第2章 疾病概要

  • 簡介

第3章 產品的評估

  • 簡介
  • 產品系列
  • FDA回收
  • 臨床實驗

第4章 台灣的微創 (MIS) 脊椎移植市場概要

  • 簡介
  • 匯率
  • 市場概要
  • 趨勢分析:各市場區隔
  • 促進因素及阻礙因素
    • 推動市場要素
    • 市場阻礙因素
  • 競爭市場佔有率分析
  • M&A
  • 企業簡介
  • SWOT分析

第5章 治療數量

  • 簡介
  • 治療

第6章 微創 (MIS) 椎間設備市場

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 促進因素及阻礙因素
    • 推動市場要素
    • 市場阻礙因素
  • 競爭市場佔有率分析

第7章 微創 (MIS) 椎弓骨釘市場

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 促進因素及阻礙因素
    • 推動市場要素
    • 市場阻礙因素
  • 競爭市場佔有率分析

第8章 微創 (MIS) 儀器市場

  • 簡介
  • 市場分析與預測
  • 促進因素及阻礙因素
    • 推動市場要素
    • 市場阻礙因素
  • 競爭市場佔有率分析

簡稱

附錄:企業的新聞稿

目錄
Product Code: iDATA_TWMIS18_MS

The Taiwanese minimally invasive spinal implant market includes the markets for MIS interbody devices, MIS pedicle screws and MIS instrumentation. In 2017, the largest segment in the total MIS implant market was the MIS pedicle screw market segment.

In 2017, the largest segment in the total MIS implant market was the MIS pedicle screw market segment. The major driving force behind growth in the MIS pedicle screw market is the perceived physiological benefits of minimally invasive surgery to the patient. These include reduced trauma, shorter hospital stays, lower post-operative medication use and a quicker return to work. The MIS pedicle screw market is expected to increasingly cannibalize revenue from the traditional cervical and thoracolumbar fixation markets.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

TAIWANESE MINIMALLY INVASIVE SPINAL IMPLANT MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1. INTRODUCTION
    • 2.1.1. Degenerative Disc Disease
      • 2.1.1.1. Disc Herniation
      • 2.1.1.2. Stenosis
      • 2.1.1.3. Spondyloisthesis
      • 2.1.1.4. Arthritis
    • 2.1.2. Spinal Deformities
      • 2.1.2.1. Scoliosis
      • 2.1.2.2. Kyphosis and Lordosis
    • 2.1.3. Trauma and Tumor
    • 2.1.4. Vertebral Compression Fractures
      • 2.1.4.1. Osteoporosis
      • 2.1.4.2. Vertebral Compression Fractures

PRODUCT ASSESSMENT

  • 3.1. INTRODUCTION
  • 3.2. PRODUCT PORTFOLIOS
    • 3.2.1. Cervical Fixation
      • 3.2.1.1. Anterior Cervical Fixation
      • 3.2.1.1.1. Constrained
      • 3.2.1.1.2. Semi-Constrained
      • 3.2.1.1.3. Dynamic
      • 3.2.1.1.4. Bioresorbable
      • 3.2.1.2. Posterior Cervical Fixation
    • 3.2.2. Thoracolumbar Fixation
      • 3.2.2.1. Traditional Systems
      • 3.2.2.2. Minimally Invasive Systems
    • 3.2.3. Interbody Devices
      • 3.2.3.1. Approaches
      • 3.2.3.1.1. ALIF
      • 3.2.3.1.2. PLIF
      • 3.2.3.1.3. TLIF
      • 3.2.3.1.4. Minimally Invasive PLIF
      • 3.2.3.1.5. Minimally Invasive TLIF
      • 3.2.3.1.6. LLIF
      • 3.2.3.1.7. OLIF
      • 3.2.3.1.8. Cervical
      • 3.2.3.1.9. VBR/Corpectomy
      • 3.2.3.2. Materials
      • 3.2.3.2.1. Metal
      • 3.2.3.2.2. PEEK
      • 3.2.3.2.3. Machined Bone Allograft
    • 3.2.4. Motion Preservation Devices
      • 3.2.4.1.1. Artificial Discs
      • 3.2.4.1.2. Dynamic Stabilization
      • 3.2.4.1.3. Nucleus Replacement
      • 3.2.4.1.4. Facet Arthroplasty
    • 3.2.5. Spinous Process Fixation
    • 3.2.6. Facet Fixation
    • 3.2.7. MIS Sacroiliac Joint Fusion
    • 3.2.8. Vertebral Compression Fracture Devices
      • 3.2.8.1.1. Percutaneous Vertebroplasty
      • 3.2.8.1.2. Percutaneous Vertebral Augmentation Including Kyphoplasty
    • 3.2.9. Spine Endoscopes
    • 3.2.10. Spinal Electrical Stimulation Devices
  • 3.3. FDA RECALLS
    • 3.3.1. Alphatec Spine
    • 3.3.2. DePuy Synthes
    • 3.3.3. Medtronic
    • 3.3.4. Orthofix
    • 3.3.5. Stryker
    • 3.3.6. Zimmer Biomet
  • 3.4. CLINICAL TRIALS
    • 3.4.1. DePuy Synthes
    • 3.4.2. Globus Medical
    • 3.4.3. K2M
    • 3.4.4. Medtronic
    • 3.4.5. Stryker
    • 3.4.6. Zimmer Biomet

TAIWANESE MINIMALLY INVASIVE SPINAL IMPLANT MARKET OVERVIEW

  • 4.1. INTRODUCTION
    • 4.1.1. Minimally Invasive Interbody Fusion
      • 4.1.1.1. Minimally Invasive Posterior Lumbar Interbody Fusion
      • 4.1.1.2. Minimally Invasive Transforaminal Lumbar Interbody Fusion
      • 4.1.1.3. Lateral Lumbar Interbody Fusion
      • 4.1.1.4. Oblique Lumbar Interbody Fusion
    • 4.1.2. Minimally Invasive Surgery Pedicle Screws
      • 4.1.2.1. Percutaneous MIS Systems
      • 4.1.2.2. Retractor-Based MIS Systems
  • 4.2. CURRENCY EXCHANGE RATE
  • 4.3. MARKET OVERVIEW
  • 4.4. TREND ANALYSIS BY SEGMENT
  • 4.5. DRIVERS AND LIMITERS
    • 4.5.1. Market Drivers
    • 4.5.2. Market Limiters
  • 4.6. COMPETITIVE MARKET SHARE ANALYSIS
  • 4.7. MERGERS AND ACQUISITIONS
  • 4.8. COMPANY PROFILES
    • 4.8.1. Alphatec Spine
    • 4.8.2. DePuy Synthes
    • 4.8.3. Globus Medical
    • 4.8.4. K2M
    • 4.8.5. Medtronic
    • 4.8.6. Orthofix
    • 4.8.7. Stryker
    • 4.8.8. Zimmer Biomet
  • 4.9. SWOT ANALYSIS
    • 4.9.1. DePuy Synthes
    • 4.9.2. DJO Global
    • 4.9.3. Globus Medical
    • 4.9.4. Joimax Gmbh
    • 4.9.5. K2M Inc.
    • 4.9.6. Karl Storz
    • 4.9.7. Medtronic
    • 4.9.8. Merit Medical Systems, Inc.
    • 4.9.9. NuVasive
    • 4.9.10. Orthofix
    • 4.9.11. Paradigm Spine
    • 4.9.12. Richard Wolf
    • 4.9.13. SI-Bone
    • 4.9.14. Spinal Kinetic
    • 4.9.15. Stryker
    • 4.9.16. Zimmer Biomet

PROCEDURE NUMBERS

  • 5.1. INTRODUCTION
  • 5.2. PROCEDURES
    • 5.2.1. Minimally Invasive Spinal Procedures
    • 5.2.2. MIS Interbody Device Procedures
      • 5.2.2.1. Total MIS Interbody Device Procedures
      • 5.2.2.1.1. Total Levels Treated by MIS Interbody Devices
      • 5.2.2.2. MIPLIF Procedures
      • 5.2.2.3. MITLIF Procedures
      • 5.2.2.4. LLIF Procedures
      • 5.2.2.5. OLIF Procedures
    • 5.2.3. MIS Thoracolumbar Fixation Procedures
      • 5.2.3.1. Total MIS Thoracolumbar Fixation Procedures
      • 5.2.3.1.1. Total Levels Treated by Total MIS Pedicle Screws
      • 5.2.3.2. Retractor MIS Thoracolumbar Fixation Procedures
      • 5.2.3.3. Percutaneous MIS Thoracolumbar Fixation Procedures

MINIMALLY INVASIVE INTERBODY DEVICE MARKET

  • 6.1. INTRODUCTION
    • 6.1.1. Approach Types
      • 6.1.1.1. Minimally Invasive Posterior Lumbar Interbody Fusion
      • 6.1.1.2. Minimally Invasive Transforaminal Lumbar Interbody Fusion
      • 6.1.1.3. Lateral Lumbar Interbody Fusion
      • 6.1.1.4. Direct Lateral Interbody Fusion
      • 6.1.1.5. eXtreme Lateral Interbody Fusion
      • 6.1.1.6. Guided Lateral Interbody Fusion
      • 6.1.1.7. Oblique Lateral Interbody Fusion
  • 6.2. MARKET OVERVIEW
  • 6.3. MARKET ANALYSIS AND FORECAST
    • 6.3.1. Total MIS Interbody Device Market
    • 6.3.2. MIPLIF Market
    • 6.3.3. MITLIF Market
    • 6.3.4. LLIF Market
    • 6.3.5. OLIF Market
  • 6.4. DRIVERS AND LIMITERS
    • 6.4.1. Market Drivers
    • 6.4.2. Market Limiters
  • 6.5. COMPETITIVE MARKET SHARE ANALYSIS

MINIMALLY INVASIVE PEDICLE SCREW MARKET

  • 7.1. INTRODUCTION
    • 7.1.1. Percutaneous MIS Systems
    • 7.1.2. Retractor-Based MIS Systems
  • 7.2. MARKET OVERVIEW
  • 7.3. MARKET ANALYSIS AND FORECAST
    • 7.3.1. Total MIS Pedicle Screw Market
    • 7.3.2. Retractor MIS Pedicle Screw Market
    • 7.3.3. Percutaneous MIS Pedicle Screw Market
  • 7.4. DRIVERS AND LIMITERS
    • 7.4.1. Market Drivers
    • 7.4.2. Market Limiters
  • 7.5. COMPETITIVE MARKET SHARE ANALYSIS

MINIMALLY INVASIVE INSTRUMENTATION MARKET

  • 8.1. INTRODUCTION
  • 8.2. MARKET ANALYSIS AND FORECAST
  • 8.3. DRIVERS AND LIMITERS
    • 8.3.1. Market Drivers
    • 8.3.2. Market Limiters
  • 8.4. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

APPENDIX: COMPANY PRESS RELEASES

  • 10.1. INTRODUCTION
  • 10.2. PRESS RELEASES
    • 10.2.1. Alphatec Spine
      • 10.2.1.1. Alphatec Holdings Announces Board and Executive Leadership Changes
      • 10.2.1.2. Alphatec Holdings Announces Third Quarter 2016 Revenue and Financial Results
      • 10.2.1.3. Alphatec Holdings Announces Company Updates
      • 10.2.1.4. Alphatec Holdings Announces Company Updates
      • 10.2.1.5. Alphatec Holdings Completes Sale of International Business to Globus Medical
      • 10.2.1.6. Alphatec Holdings Announces Sale of International Business to Globus Medical
      • 10.2.1.7. Alphatec Holdings Announces Fourth Quarter and Full Year 2015 Revenue and Financial Results
      • 10.2.1.8. Alphatec Holdings Announces Third Quarter 2015 Revenue and Financial Results
      • 10.2.1.9. Alphatec Spine Announces Retirement of James R. Glynn From Its Board of Directors; Donald A. Williams Appointed Audit Committee Chairman
      • 10.2.1.10. Preliminary Third Quarter 2015 Revenue Results in Advance of Attendance at the 30th Annual North American Spine Society (Nass) Meeting in Chicago, Illinois
      • 10.2.1.11. Alphatec Spine Introduces New Titanium-Coated PEEK Interbody Fusion System
      • 10.2.1.12. Alphatec Spine Launches Alphatec Neocore? Osteoconductive Matrix in the U.S.
      • 10.2.1.13. Alphatec's Less-Invasive Arsenal? Cortical Bone Fixation System Successfully Used in Over 50 Patients
      • 10.2.1.14. Alphatec's Arsenal? Spinal Fixation System Further Expanded to Address Broader Market
      • 10.2.1.15. Alphatec Holdings Announces Second Quarter 2015 Revenue and Financial Results
      • 10.2.1.16. Alphatec Spine Announces Appointment of Donald A. Williams to its Board of Directors
      • 10.2.1.17. Alphatec Holdings Announces First Quarter 2015 Revenue and Financial Results
      • 10.2.1.18. Alphatec Holdings Announces Fourth Quarter and Full Year 2014 Revenue and Financial Results
    • 10.2.2. DePuy Synthes
      • 10.2.2.1. SYNFIX® Evolution Secured Spacer System Provides Superior Biomechanical Stability1 with Enhanced Instrumentation Designed for Surgical Efficiency
      • 10.2.2.2. DePuy Synthes Companies Introduces Zero-Profile Plate with Allograft Spacer for Neck
      • 10.2.2.3. DePuy Synthes Companies Launches Portable Spine Imaging System to Help Expand Access to Advanced Visualization and Improve Patient Outcomes
      • 10.2.2.4. Johnson & Johnson Medical Devices Companies Value-Based Solutions Help Health Systems Address Proposed Mandatory CMS Plan for Episode Payment Models
      • 10.2.2.5. New Hand System From DePuy Synthes Companies Designed to Address Patient and Surgeon Needs Through Innovation and Versatility
      • 10.2.2.6. DePuy Synthes Announces Agreement with Materialise for 3D-Printed Titanium Cranio-Facial Implants
      • 10.2.2.7. DePuy Synthes Companies Announces Acquisition of BioMedical Enterprises, Inc., A Leader in Small Bone Fixation
      • 10.2.2.8. DEPUY SYNTHES COMPANIES ANNOUNCES NEW STRATEGIC ALLIANCE WITH EXPERTS IN BUNDLED PAYMENTS
      • 10.2.2.9. DePuy Synthes Spine Introduces EXPEDIUM VERSE® Spinal System
      • 10.2.2.10. DEPUY SYNTHES COMPANIES ANNOUNCES FIVE-YEAR COOPERATION AGREEMENT WITH THE AO FOUNDATION
      • 10.2.2.11. DEPUY SYNTHES COMPANIES ENHANCES ADULT DEFORMITY OFFERING WITH FOUR NEW PRODUCTS AND A NEW EDUCATION SOLUTION
      • 10.2.2.12. TWO NEW SOLUTIONS FROM DEPUY SYNTHES COMPANIES GO 'BEYOND THE IMPLANT' FOR ORTHOPAEDIC PATIENTS
      • 10.2.2.13. NEW ADVANCED NAILING SYSTEM FROM DEPUY SYNTHES COMPANIES DESIGNED TO IMPROVE SURGICAL TREATMENT OF HIP FRACTURES
      • 10.2.2.14. DEPUY SYNTHES COMPANIES ACQUIRES OLIVE MEDICAL CORPORATION
      • 10.2.2.15. DEPUY SYNTHES SPINE ANNOUNCES EXPANDED INDICATION FOR SYNAPSE™ OCCIPITAL-CERVICAL-THORACIC (OCT) SYSTEM
    • 10.2.3. Globus Medical
      • 10.2.3.1. Globus Medical Reports Third Quarter 2016 Results
      • 10.2.3.2. Globus Medical Launches QUARTEX™ OCT Stabilization System
      • 10.2.3.3. Globus Medical Launches INDEPENDENCE MIS™, a Minimally Invasive ALIF Integrated Plate-Spacer
      • 10.2.3.4. Globus Medical Completes Acquisition of Alphatec's International Business
      • 10.2.3.5. Globus Medical Announces the Acquisition of Alphatec's International Business
      • 10.2.3.6. Globus Medical Reports Second Quarter 2016 Results
      • 10.2.3.7. Globus Medical Appoints Eric Ian Schwartz as Senior Vice President and General Counsel
      • 10.2.3.8. Globus Medical Reports First Quarter 2016 Results
      • 10.2.3.9. Globus Medical Reports Full Year and Fourth Quarter 2015 Results
      • 10.2.3.10. Globus Medical Reports Preliminary Fourth Quarter and Full Year Record Sales Results
      • 10.2.3.11. Globus Medical Reports Third Quarter 2015 Results
      • 10.2.3.12. Globus Medical Announces Key Executive Changes
      • 10.2.3.13. James R. Tobin, former CEO of Boston Scientific, Joins Globus Medical Board of Directors
      • 10.2.3.14. Globus Medical Reports Second Quarter 2015 Results
      • 10.2.3.15. Globus Medical Announces RISE®-L, an Expandable Lateral Interbody Fusion Device
      • 10.2.3.16. Globus Medical Reports First Quarter 2015 Results
      • 10.2.3.17. Globus Medical Appoints Daniel Scavilla as Senior Vice President and CFO
      • 10.2.3.18. Globus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results
    • 10.2.4. K2M
      • 10.2.4.1. K2M Group Holdings, Inc. Reports Third Quarter 2016 Financial Results with U.S. Revenue Growth of 17% year-over-year; Updates Fiscal Year 2016 Outlook
      • 10.2.4.2. K2M Announces US Launch of Comprehensive 3D Solutions at the 2016 North American Spine Society Annual Meeting
      • 10.2.4.3. K2M Expands 3D-Printed MIS CASCADIA™ Lateral Interbody System Featuring Lamellar 3D Titanium Technology™
      • 10.2.4.4. K2M Expands MESA® Platform with FDA Clearance for Growing Spine Application
      • 10.2.4.5. K2M Group Holdings, Inc. Reports Second Quarter 2016 Financial Results; Reaffirms Fiscal Year 2016 Outlook
      • 10.2.4.6. Spine Publication Article Demonstrates K2M's MESA Rail™ Achieved "Significantly Better Curve Correction" in Treating Adolescent Idiopathic Scoliosis (AIS)
      • 10.2.4.7. K2M Enhances 3D-Printed Spine Portfolio Following FDA Clearance of Two CASCADIA™ Interbody Systems Featuring Lamellar 3D Titanium Technology™
      • 10.2.4.8. Research Supporting Favorable Findings on K2M's RAVINE® Lateral Access System to Be Presented at SpineWeek 2016
      • 10.2.4.9. K2M Group Holdings, Inc. Reports First Quarter 2016 Financial Results, Led by U.S. Revenue Growth of 20% year-over-year, and Updates 2016 Outlook
      • 10.2.4.10. K2M's MESA® Mini and DENALI® Mini Spinal Systems Receive Additional FDA Clearance for Posterior Cervical Spine Fixation
      • 10.2.4.11. K2M Group Holdings, Inc. Reports Record Revenue for Fiscal Year 2015, with Complex Spine Growth of 17%
      • 10.2.4.12. K2M Receives CE Mark for Its Next-Generation RHINE™ Cervical Disc System
      • 10.2.4.13. K2M Group Holdings, Inc. Reports Preliminary Fourth Quarter and Full Year 2015 Financial Results With 17% Annual Growth
      • 10.2.4.14. K2M Expands Minimally Invasive Spine Portfolio With Addition of Its CASCADIA™ Lateral Interbody System Featuring Lamellar Titanium Technology™
      • 10.2.4.15. K2M Expands MIS Portfolio With Addition of Its EVEREST® Minimally Invasive XT Spinal System
      • 10.2.4.16. K2M Group Holdings, Inc. Reports Third Quarter Revenue Growth of 16.7% in Constant Currency and Increases Fiscal Year 2015 Revenue Guidance Range
      • 10.2.4.17. K2M to Unveil 3D Printed Lamellar Titanium Technology? at the 2015 North American Spine Society Annual Meeting
      • 10.2.4.18. K2M Announces U.S. Launch of the EVERESTR Deformity Spinal System at the Scoliosis Research Society 50th Annual Meeting
      • 10.2.4.19. K2M Enhances PYRENEESR Product Family With the Addition of Its Mono Cervical Plate System
      • 10.2.4.20. K2M Group Holdings, Inc. Reports U.S. Complex Spine Growth of 24% and Financial Results for the Second Quarter of Fiscal Year 2015
      • 10.2.4.21. K2M Expands Presence in Asia With Six Product Launches in Singapore and Hong Kong and Announces Participation at the IMAST 2015 Conference
      • 10.2.4.22. K2M Group Holdings, Inc. Reports Preliminary Second Quarter Financial Results Including Domestic Revenue Growth of 24%
      • 10.2.4.23. K2M Launches the MESAR 2 Deformity Spinal System in the US
      • 10.2.4.24. K2M Group Holdings, Inc. Appoints Michael Turpin to Board of Directors
      • 10.2.4.25. K2M Group Holdings, Inc. Reports First Quarter Revenue Growth of 21% and First Quarter of Fiscal Year 2015 Financial Results; Complex Spine Growth of 19% Year-Over-Year
      • 10.2.4.26. K2M Announces Enhanced Complex Spine Portfolio With Addition of Its Innovative NILE? Alternative Fixation Spinal System
      • 10.2.4.27. K2M Group Holdings Inc. Reports 2014 Revenue Growth of 18.5% Fourth Quarter and Full Year 2014 Financial Results; Fourth Quarter Complex Spine Growth of 20.5% Year-over-Year
      • 10.2.4.28. K2M Receives FDA 510(k) Clearance for the Next Generation of Its Innovative Complex Spine MESAR Technology
      • 10.2.4.29. K2M Group Holdings, Inc. Reports Preliminary Fourth Quarter and Full Year 2014 Financial Results, Including Q4 US Complex Spine Growth of 20%
    • 10.2.5. Medtronic
      • 10.2.5.1. Medtronic Announces U.S. Launch of Integrated Health Solutions with University Hospitals Agreement
      • 10.2.5.2. Medtronic Reports Second Quarter Financial Results
      • 10.2.5.3. Medtronic Releases FY16 Integrated Performance Report
      • 10.2.5.4. MiniMed® Connect Mobile Accessory for Android Now Available from Medtronic
      • 10.2.5.5. Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
      • 10.2.5.6. Medtronic Reports First Quarter Financial Results
      • 10.2.5.7. Medtronic Launches Revamped Minimally Invasive Spine Fusion Procedures
      • 10.2.5.8. Medtronic Strengthens Commitment to Asia Pacific
      • 10.2.5.9. Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results
      • 10.2.5.10. Medtronic Welcomes Karen L. Parkhill as Its New Chief Financial Officer
      • 10.2.5.11. Medtronic Announces the Pricing Terms of Its Cash Tender Offer of Certain Outstanding Debt Securities Issued by Medtronic, Inc. and Covidien International Finance S.A.
      • 10.2.5.12. Medtronic Announces the Early Results and Upsizing of Its Cash Tender Offer for Certain Outstanding Debt Securities Issued by Medtronic, Inc. and Covidien International Finance S.A.
      • 10.2.5.13. Medtronic Statement on U.S. Department of Treasury's Recent Temporary and Proposed Regulations
      • 10.2.5.14. Medtronic Announces Cash Tender Offer for Up to $2.75 Billion Aggregate Purchase Price of Certain Outstanding Debt Securities Issued by Medtronic, Inc. and Covidien International Finance S.A.
      • 10.2.5.15. Medtronic Reports Third Quarter Financial Results
    • 10.2.6. NuVasive
      • 10.2.6.1. NuVasive Reports Third Quarter 2016 Financial Results
      • 10.2.6.2. NuVasive Appoints Joan Stafslien as Executive Vice President, General Counsel
      • 10.2.6.3. NuVasive Receives FDA 510(k) Clearance Reinforcing Comprehensive Portfolio Supporting Pediatric, Adolescent and Adult Spinal Deformity Patients
      • 10.2.6.4. NuVasive Names Jason M. Hannon President and Chief Operating Officer; Patrick S. Miles Assumes Role of Vice Chairman
      • 10.2.6.5. NuVasive's MAGEC System Featured in Live Surgery Event at the Spine Hospital at NewYork-Presbyterian
      • 10.2.6.6. NuVasive Secures CMS Add-On Payment for Innovative MAGEC System
      • 10.2.6.7. Michael D. O'Halleran and Patrick S. Miles Elected to NuVasive Board of Directors
      • 10.2.6.8. NuVasive Reports Second Quarter 2016 Financial Results
      • 10.2.6.9. NuVasive to Feature Industry-Leading Portfolio at 23rd International Meeting on Advanced Spine Technologies
      • 10.2.6.10. NuVasive Completes Acquistion of Biotronic NeuroNetwork
      • 10.2.6.11. NuVasive Agrees to Settle Patent Litigation With Medtronic
      • 10.2.6.12. NuVasive to Acquire Biotronic NeuroNetwork
      • 10.2.6.13. NuVasive Launches Next Generation Biologics Technology
      • 10.2.6.14. NuVasive Reports First Quarter 2016 Financial Results
      • 10.2.6.15. NuVasive Launches Integrated Global Alignment (iGA?) Platform at BritSpine 2016
      • 10.2.6.16. NuVasive Announces Regulatory Approval of Reline? Posterior Fixation Technology in Japan
      • 10.2.6.17. NuVasive Announces Agreement to Acquire Brazilian Distributor Mega Surgical
      • 10.2.6.18. NuVasive Elects Robert F. Friel and Donald J. Rosenberg to Board of Directors
      • 10.2.6.19. NuVasive Reports Fourth Quarter and Full Year 2015 Financial Results
      • 10.2.6.20. NuVasive Announces Select Preliminary Full-Year 2015 Financial Results and Reiterates 2016 Outlook
      • 10.2.6.21. NuVasive to Acquire Ellipse Technologies
    • 10.2.7. Orthofix
      • 10.2.7.1. Orthofix Announces Appointment of Alex Lukianov to Board of Directors
      • 10.2.7.2. Orthofix International Reports Third Quarter 2016 Financial Results
      • 10.2.7.3. Orthofix International Reports Second Quarter 2016 Financial Results
      • 10.2.7.4. Orthofix Announces Japanese Approval and Market Launch of PHOENIX Minimally Invasive Spinal Fixation System
      • 10.2.7.5. Orthofix Announces 510(k) Clearance and US Limited Market Launch of FORZA PTC Interbody Spacer System
      • 10.2.7.6. Orthofix International Reports First Quarter 2016 Financial Results
      • 10.2.7.7. Orthofix Announces Appointment of Michael Paolucci to Board of Directors
      • 10.2.7.8. Orthofix International Reports Fourth Quarter and Fiscal 2015 Financial Results
      • 10.2.7.9. Orthofix Study Shows Pulsed Electromagnetic Field Therapy May Reduce Cellular Inflammation Associated with Disc Degeneration
      • 10.2.7.10. Orthofix Announces Preliminary Fourth Quarter 2015 and Full Year Net Sales Results
      • 10.2.7.11. Orthofix International Reports Third Quarter 2015 Financial Results
      • 10.2.7.12. Orthofix Announces Publication of Data Confirming the Clinical Benefits of Trinity Evolution Cellular Bone Allograft in Foot and Ankle Procedures
      • 10.2.7.13. Orthofix International Reports Second Quarter 2015 Financial Results
      • 10.2.7.14. Orthofix Announces the Addition of Lilly Marks to Board of Directors
      • 10.2.7.15. Orthofix International Reports First Quarter 2015 Financial Results
      • 10.2.7.16. Orthofix International Reports Fourth Quarter and Fiscal 2014 Financial Results
      • 10.2.7.17. Orthofix International Secures Option to Acquire eNeura, Inc.
      • 10.2.7.18. Orthofix International Reports Third Quarter 2014 Results and Announces Filing of Restated Financial Statements
      • 10.2.7.19. Orthofix International Provides Update Regarding NASDAQ Listing Matters
      • 10.2.7.20. Orthofix International Announces Preliminary Net Sales Estimates for the 2014 and 2013 Fiscal Years and Updated Timing Objectives for Completion of Amended and Late Filings
    • 10.2.8. Stryker
      • 10.2.8.1. Stryker announces multi-year partnership with Indo UK Institute of Health to deliver affordable orthopaedic care in India
      • 10.2.8.2. Stryker reports third quarter 2016 results
      • 10.2.8.3. Stryker reports second quarter 2016 results
      • 10.2.8.4. Stryker acquires Stanmore Implants Worldwide Limited
      • 10.2.8.5. Stryker announces completion of the acquisition of vertebral compression fracture portfolio from BD
      • 10.2.8.6. Stryker reports first quarter 2016 results
      • 10.2.8.7. Stryker reports first quarter 2016 results
      • 10.2.8.8. Stryker completes acquisition of Physio-Control International, Inc.
      • 10.2.8.9. Stryker completes the acquisition of Synergetics USA, Inc.'s Neuro Portfolio
      • 10.2.8.10. Stryker completes acquisition of Sage Products, LLC
      • 10.2.8.11. Stryker Announces Definitive Agreement to Acquire Physio-Control International, Inc. for $1.28 Billion
      • 10.2.8.12. Stryker Announces Definitive Agreement to Acquire Synergetics USA, Inc.'s Neuro Portfolio
      • 10.2.8.13. Stryker Announces Definitive Agreement to Acquire Sage Products, LLC from Madison Dearborn Partners for $2.775 Billion
      • 10.2.8.14. Stryker Announces the Retirement of William R. Jellison and the promotion of Glenn S. Boehnlein to Vice President, Chief Financial Officer
      • 10.2.8.15. Stryker Reports 2015 Results and 2016 Outlook
      • 10.2.8.16. Stryker Provides 2015 Preliminary Sales Results and Increases Adjusted Earnings Guidance
      • 10.2.8.17. Stryker Reports Third Quarter 2015 Results
      • 10.2.8.18. Stryker Completes Acquisition of Muka Metal, A.S.
      • 10.2.8.19. Stryker Receives FDA Clearance For Mako Total Knee Application
      • 10.2.8.20. Stryker Announces Definitive Agreement to Acquire Muka Metal, A.S.
      • 10.2.8.21. Stryker Reports First Quarter 2015 Results
      • 10.2.8.22. Stryker Reports 2014 Results and 2015 Outlook
      • 10.2.8.23. Stryker Provides 2014 Preliminary Results and Updates 2015 Foreign Exchange Outlook
      • 10.2.8.24. Stryker Acquires the Assets of CHG Hospital Beds, Inc.
    • 10.2.9. Zimmer Biomet
      • 10.2.9.1. Zimmer Biomet Strengthens Spine Offering with PrimaGen Advanced™ Allograft
      • 10.2.9.2. Patient-matched glenoid implants allow surgeons to address extensive bone loss and deformities.
      • 10.2.9.3. Zimmer Biomet Reports Positive Update on Biologics Pipeline Following a Preliminary Analysis of Data from the First Pivotal Trial of Stem Cell Therapy for Critical Limb Ischemia to Reach Completion
      • 10.2.9.4. Zimmer Biomet Responsive Statement on Product Supply Matters
      • 10.2.9.5. Zimmer Biomet Reports Third Quarter 2016 Financial Results
      • 10.2.9.6. Zimmer Biomet Acquires RespondWell® Telerehabilitation Platform for Zimmer Biomet Signature Solutions
      • 10.2.9.7. Zimmer Biomet Announces Positive Comparative Data from 7-Year Follow-Up Study of Mobi-C® Cervical Disc Prosthesis for Cervical Disc Replacement
      • 10.2.9.8. Zimmer Biomet's Mobi-C® Cervical Disc Becomes Most Widely Covered Intervertebral Disc Prosthesis for Cervical Disc Replacement
      • 10.2.9.9. Zimmer Biomet Expands Foot and Ankle Portfolio Through Exclusive Global Distribution Agreement with Nextremity Solutions, Inc.
      • 10.2.9.10. Zimmer Biomet Adds 3D Range-of-Motion Simulation Capability with Strategic Acquisition of Clinical Graphics
      • 10.2.9.11. Zimmer Biomet Strengthens Musculoskeletal Diagnostic Offering with Acquisition of CD Diagnostics
      • 10.2.9.12. Zimmer Biomet Reports Second Quarter 2016 Financial Results
      • 10.2.9.13. Zimmer Biomet Unveils Signature Solutions™
      • 10.2.9.14. Zimmer Biomet Announces Multi-Year Collaboration with Indo UK Institutes of Health to Deliver Affordable and Accessible Healthcare in India
      • 10.2.9.15. Zimmer Biomet Completes Tender Offer for Outstanding Shares of LDR Holding Corporation
      • 10.2.9.16. Zimmer Biomet Celebrates Four Decades of Excellence with the 40th Anniversary of the Oxford® Partial Knee System
      • 10.2.9.17. Zimmer Biomet Announces Early Termination of HSR Waiting Period
      • 10.2.9.18. Zimmer Biomet Announces Enhancements to Joint Reconstruction Portfolio for the Treatment of Patients with Significant Bone Loss
      • 10.2.9.19. Zimmer Biomet To Acquire LDR To Enhance Innovation And Growth Of Spine Business
      • 10.2.9.20. Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2016
      • 10.2.9.21. Zimmer Biomet Completes Acquisition of Cayenne Medical
      • 10.2.9.22. Zimmer Biomet Holdings, Inc. Reports First Quarter 2016 Financial Results
      • 10.2.9.23. Zimmer Biomet Enters into Definitive Agreement to Acquire Cayenne Medical

LIST OF CHARTS

  • Chart 1-1: Minimally Invasive Spinal Implant Market by Segment, Taiwan, 2014 - 2024
  • Chart 1-2: Minimally Invasive Spinal Implant Market by Segment, Taiwan, 2017 & 2024
  • Chart 4-1: Minimally Invasive Spinal Implant Market by Segment, Taiwan, 2014 - 2024
  • Chart 4-2: Minimally Invasive Spinal Implant Market Breakdown, Taiwan, 2017
  • Chart 4-3: Minimally Invasive Spinal Implant Market Breakdown, Taiwan, 2024
  • Chart 4-4: Minimally Invasive Spinal Implant Market Growth by Segment, Taiwan, 2014 - 2024
  • Chart 4-5: Leading Competitors, Minimally Invasive Spinal Implant Market, Taiwan, 2017
  • Chart 5-1: Minimally Invasive Spinal Implant Procedures by Segment, Taiwan, 2014 - 2024
  • Chart 5-2: Total MIS Interbody Device Procedures by Segment, Taiwan, 2014 - 2024
  • Chart 5-3: Total MIS Thoracolumbar Fixation Procedures by Segment, Taiwan, 2014 - 2024
  • Chart 6-1: MIS Interbody Device Market by Segment, Taiwan, 2014 - 2024
  • Chart 6-2: MIS Interbody Device Market Breakdown, Taiwan, 2017
  • Chart 6-3: MIS Interbody Device Market Breakdown, Taiwan, 2024
  • Chart 6-4: Total MIS Interbody Device Market, Taiwan, 2014 - 2024
  • Chart 6-5: MIPLIF Market, Taiwan, 2014 - 2024
  • Chart 6-6: MITLIF Market, Taiwan, 2014 - 2024
  • Chart 6-7: LLIF Market, Taiwan, 2014 - 2024
  • Chart 6-8: OLIF Market, Taiwan, 2014 - 2024
  • Chart 6-9: Leading Competitors, MIS Interbody Device Market, Taiwan, 2017
  • Chart 7-1: MIS Pedicle Screw Market by Segment, Taiwan, 2014 - 2024
  • Chart 7-2: MIS Pedicle Screw Market Breakdown, Taiwan, 2017
  • Chart 7-3: MIS Pedicle Screw Market Breakdown, Taiwan, 2024
  • Chart 7-4: Total MIS Pedicle Screw Market, Taiwan, 2014 - 2024
  • Chart 7-5: Retractor MIS Pedicle Screw Market, Taiwan, 2014 - 2024
  • Chart 7-6: Percutaneous MIS Pedicle Screw Market, Taiwan, 2014 - 2024
  • Chart 7-7: Leading Competitors, MIS Pedicle Screw Market, Taiwan, 2017
  • Chart 8-1: MIS Instrumentation Market, Taiwan, 2014 - 2024

LIST OF FIGURES

  • Figure 1-1: Minimally Invasive Spinal Implant Market Share Ranking by Segment, Taiwan, 2017
  • Figure 1-2: Companies Researched in this Report, Taiwan, 2017
  • Figure 1-3: Factors Impacting the Minimally Invasive Spinal Implant Market by Segment, Taiwan
  • Figure 1-4: Recent Events in the Minimally Invasive Spinal Implant Market, Taiwan, 2015 - 2018
  • Figure 1-5: Minimally Invasive Spinal Implant Procedures Covered, Taiwan, 2017
  • Figure 1-6: Minimally Invasive Spinal Implant Markets Covered, Taiwan, 2017
  • Figure 1-7: Key Report Updates
  • Figure 1-8: Version History
  • Figure 3-1: Cervical Fixation Devices by Company (1 of 2)
  • Figure 3-2: Cervical Fixation Devices by Company (2 of 2)
  • Figure 3-3: Thoracolumbar Fixation Devices by Company (1 of 2)
  • Figure 3-4: Thoracolumbar Fixation Devices by Company (2 of 2)
  • Figure 3-5: Interbody Devices by Company (1 of 2)
  • Figure 3-6: Interbody Devices by Company (2 of 2)
  • Figure 3-7: Cervical Artificial Disc Devices by Company
  • Figure 3-8: Lumbar Artificial Disc Devices by Company
  • Figure 3-9: Dynamic Posterior Stabilization Devices by Company
  • Figure 3-10: Interspinous Process Decompression Devices by Company
  • Figure 3-11: Spinous Process Fixation Devices by Company
  • Figure 3-12: Facet Fixation Devices by Company
  • Figure 3-13: MIS Sacroiliac Joint Devices by Company
  • Figure 3-14: Vertebral Compression Fracture Devices by Company
  • Figure 3-15: Spine Endoscopes by Company
  • Figure 3-16: Spinal Electrical Stimulation Devices by Company
  • Figure 3-17: Class 2 Device Recall Alphatec Spine
  • Figure 3-18: Class 2 Device Recall DePuy Synthes
  • Figure 3-19: Class 2 Device Recall DePuy Synthes
  • Figure 3-20: Class 2 Device Recall Medtronic
  • Figure 3-21: Class 2 Device Recall Medtronic
  • Figure 3-22: Class 2 Device Recall Medtronic
  • Figure 3-23: Class 2 Device Recall Medtronic
  • Figure 3-24: Class 2 Device Recall Orthofix
  • Figure 3-25: Class 2 Device Recall Orthofix
  • Figure 3-26: Class 2 Device Recall Orthofix
  • Figure 3-27: Class 2 Device Recall Orthofix
  • Figure 3-28: Class 2 Device Recall Stryker
  • Figure 3-29: Class 2 Device Recall Stryker
  • Figure 3-30: Class 2 Device Recall Zimmer Biomet
  • Figure 3-31: An ACDF Multi-Center Study Using ViviGen Cellular Bone Matrix
  • Figure 3-32: A Retrospective Study Using CALIBER® TLIF Expandable Spacer in the Treatment of DDD: 2 Year Follow-up.
  • Figure 3-33: Comparing Pedicle Screw Systems for the Treatment of Adolescent Paediatric Spine Deformity
  • Figure 3-34: A Prospective, 5-Year Global Study on MAST™
  • Figure 3-35: Spinal Cord Stimulation to Treat Post-operative Atrial Fibrillation (SCS-PAF)
  • Figure 3-36: OLIF25™ /OLIF51™ Study
  • Figure 3-37: AccuLIF® PROSPECTIVE PATIENT OUTCOMES STUDY (APROPOS)
  • Figure 3-38: Post-Market Surveillance Study of the TM Ardis Interbody Fusion System
  • Figure 4-1: Currency Exchange Rate, 2017
  • Figure 4-2: Minimally Invasive Spinal Implant Market by Segment, Taiwan, 2014 - 2024 (US$M)
  • Figure 4-3: Minimally Invasive Spinal Implant Market by Segment, Taiwan, 2014 - 2024 (NT$M)
  • Figure 4-4: Minimally Invasive Spinal Implant Market Growth by Segment, Taiwan, 2014 - 2024
  • Figure 4-5: Drivers and Limiters, Minimally Invasive Spinal Implant Market, Taiwan, 2017
  • Figure 4-6: Leading Competitors, Minimally Invasive Spinal Implant Market, Taiwan, 2017
  • Figure 4-7: SWOT Analysis, DePuy Synthes, 2017
  • Figure 4-8: SWOT Analysis, DJO Global, 2017
  • Figure 4-9: SWOT Analysis, Globus Medical, 2017
  • Figure 4-10: SWOT Analysis, Joimax, 2017 (1 of 2)
  • Figure 4-11: SWOT Analysis, Joimax, 2017 (2 of 2)
  • Figure 4-12: SWOT Analysis, K2M, 2017 (1 of 2)
  • Figure 4-13: SWOT Analysis, K2M, 2017 (2 of 2)
  • Figure 4-14: SWOT Analysis, Karl Storz, 2017
  • Figure 4-15: SWOT Analysis, Medtronic, 2017
  • Figure 4-16: SWOT Analysis, Merit Medical Systems, 2017
  • Figure 4-17: SWOT Analysis, NuVasive, 2017
  • Figure 4-18: SWOT Analysis, Orthofix, 2017
  • Figure 4-19: SWOT Analysis, Paradigm Spine, 2017
  • Figure 4-20: SWOT Analysis, Richard Wolf, 2017
  • Figure 4-21: SWOT Analysis, SI-Bone, 2017
  • Figure 4-22: SWOT Analysis, Spinal Kinetic, 2017
  • Figure 4-23: SWOT Analysis, Stryker, 2017
  • Figure 4-24: SWOT Analysis, Zimmer Biomet, 2017 (1 of 2)
  • Figure 5-1: Minimally Invasive Spinal Implant Procedures by Segment, Taiwan, 2014 - 2024
  • Figure 5-2: Levels Treated by Minimally Invasive Spinal Implant Procedures by Segment, Taiwan, 2014 - 2024
  • Figure 5-3: Total MIS Interbody Device Procedures by Segment, Taiwan, 2014 - 2024
  • Figure 5-4: Total Levels Treated by MIS Interbody Devices by Segment, Taiwan, 2014 - 2024
  • Figure 5-5: MIPLIF Procedures, Taiwan, 2014 - 2024
  • Figure 5-6: MITLIF Procedures, Taiwan, 2014 - 2024
  • Figure 5-7: LLIF Procedures, Taiwan, 2014 - 2024
  • Figure 5-8: OLIF Procedures, Taiwan, 2014 - 2024
  • Figure 5-9: Total MIS Thoracolumbar Fixation Procedures by Segment, Taiwan, 2014 - 2024
  • Figure 5-10: Total Levels Treated by Total MIS Pedicle Screws by Segment, Taiwan, 2014 - 2024
  • Figure 5-11: Retractor MIS Thoracolumbar Fixation Procedures, Taiwan, 2014 - 2024
  • Figure 5-12: Percutaneous MIS Thoracolumbar Fixation Procedures, Taiwan, 2014 - 2024
  • Figure 6-1: MIS Interbody Device Market by Segment, Taiwan, 2014 - 2024 (US$M)
  • Figure 6-2: MIS Interbody Device Market by Segment, Taiwan, 2014 - 2024 (NT$M)
  • Figure 6-3: Total MIS Interbody Device Market, Taiwan, 2014 - 2024
  • Figure 6-4: MIPLIF Market, Taiwan, 2014 - 2024
  • Figure 6-5: MITLIF Market, Taiwan, 2014 - 2024
  • Figure 6-6: LLIF Market, Taiwan, 2014 - 2024
  • Figure 6-7: OLIF Market, Taiwan, 2014 - 2024
  • Figure 6-8: Drivers and Limiters, MIS Interbody Device Market, Taiwan, 2017
  • Figure 6-9: Leading Competitors, MIS Interbody Device Market, Taiwan, 2017
  • Figure 7-1: MIS Pedicle Screw Market Overview by Segment, Taiwan, 2014 - 2024 (US$M)
  • Figure 7-2: MIS Pedicle Screw Market Overview by Segment, Taiwan, 2014 - 2024 (NT$M)
  • Figure 7-3: Total MIS Pedicle Screw Market, Taiwan, 2014 - 2024
  • Figure 7-4: Retractor MIS Pedicle Screw Market, Taiwan, 2014 - 2024
  • Figure 7-5: Percutaneous MIS Pedicle Screw Market, Taiwan, 2014 - 2024
  • Figure 7-6: Drivers and Limiters, MIS Pedicle Screw Market, Taiwan, 2017
  • Figure 7-7: Leading Competitors, MIS Pedicle Screw Market, Taiwan, 2017
  • Figure 8-1: MIS Instrumentation Market, Taiwan, 2014 - 2024
  • Figure 8-2: Drivers and Limiters, MIS Instrumentation Market, Taiwan, 2017
  • Figure 8-3: Leading Competitors, MIS Instrumentation Market, Taiwan, 2017
  • Figure 10-1: Press Release Summary
Back to Top